Clinical-scale lentiviral vector transduction of PBL for TCR gene therapy and potential for expression in less-differentiated cells.
about
Genetic engineering with T cell receptorsNovel human interleukin-15 agonistsThe shedding of CD62L (L-selectin) regulates the acquisition of lytic activity in human tumor reactive T lymphocytes.Global transcriptional analysis for biomarker discovery and validation in cellular therapies.Interleukin-15:Interleukin-15 receptor α scaffold for creation of multivalent targeted immune moleculesIn vitro generated anti-tumor T lymphocytes exhibit distinct subsets mimicking in vivo antigen-experienced cells.Genetic engineering of murine CD8+ and CD4+ T cells for preclinical adoptive immunotherapy studies.MicroRNAs in skin and wound healing.Potential limitations of the NSG humanized mouse as a model system to optimize engineered human T cell therapy for cancer.A simple and effective method to generate lentiviral vectors for ex vivo gene delivery to mature human peripheral blood lymphocytesGenetic redirection of T cells for cancer therapy.Critical role of γ4 chain in the expression of functional Vγ4Vδ1 T cell receptor of gastric tumour-infiltrating γδT lymphocytes.Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh TumorOptimized DNA electroporation for primary human T cell engineering.Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktails.Industrializing Autologous Adoptive Immunotherapies: Manufacturing Advances and Challenges.
P2860
Q26995677-4947B7D2-83E6-4F81-A873-8F6998138973Q33623266-70FBFD08-027B-4B10-A9B9-F194EBFCAE37Q33987699-D6E28B4C-AC6D-4670-84F6-1083E4B9A7DDQ34171422-E2CAF5D7-72D6-4F5F-842A-1D0093099FE5Q34626998-A611585D-0E30-45CE-8F0B-C0A2C4325F6DQ34827147-40000390-7664-4A46-A674-94B584D0F0C8Q35001971-34C746B8-F2A8-4C18-8DBB-7EEA3CCFB3A7Q35033659-61C13B7A-3341-494B-A0C1-87BE81D6626CQ37233539-55D446AE-AF6D-445F-9E87-CF9381E65C9FQ37358371-EEDBB023-2B3F-4DA2-8322-0772709B94A0Q37697337-0E635CB1-C02B-4AC1-AB05-149801847322Q39460093-4AB0894A-79EB-47EC-81D6-F3CEA3398291Q39647119-D9705CF3-50E7-48C2-B6B9-D8347EA6CFCBQ47548226-3BBAB6EC-2E23-407D-9446-EA27B2724F94Q50925934-A812BE06-6254-43C2-9B6F-AE4F46DC3CF0Q54940615-85275663-4341-4E69-9504-27B6461E037C
P2860
Clinical-scale lentiviral vector transduction of PBL for TCR gene therapy and potential for expression in less-differentiated cells.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Clinical-scale lentiviral vect ...... in less-differentiated cells.
@ast
Clinical-scale lentiviral vect ...... in less-differentiated cells.
@en
type
label
Clinical-scale lentiviral vect ...... in less-differentiated cells.
@ast
Clinical-scale lentiviral vect ...... in less-differentiated cells.
@en
prefLabel
Clinical-scale lentiviral vect ...... in less-differentiated cells.
@ast
Clinical-scale lentiviral vect ...... in less-differentiated cells.
@en
P2093
P2860
P1476
Clinical-scale lentiviral vect ...... in less-differentiated cells.
@en
P2093
Richard A Morgan
Shicheng Yang
Steven A Rosenberg
P2860
P304
P356
10.1097/CJI.0B013E31818817C5
P577
2008-11-01T00:00:00Z